MDPI Review Maps Biosensors’ Evolution to Integrated Systems for Molecular Diagnostics and Longitudinal Clinical Monitoring

September 6, 2026

MDPI (Biosensors Journal) International

Overview

A new review from MDPI details the transformation of biosensors from simple analytical detectors into integrated systems crucial for molecular diagnostics, longitudinal monitoring, dynamic tissue assessment, and clinical decision support. The analysis synthesizes literature from 2018-2026 on biorecognition, biointerface engineering, transduction, wearable/microneedle architectures, and CRISPR diagnostics, proposing a unified translational framework focused on system reliability and clinical utility. While benchmarking against continuous glucose monitoring, the review highlights persistent challenges in other platforms, including biofouling, matrix effects, calibration drift, and manufacturing scalability, which impede broader clinical adoption.

In Depth

Key Findings

A comprehensive review published in MDPI’s Biosensors Journal outlines the significant evolution of biosensors beyond basic analytical detection into sophisticated integrated systems. These systems are now poised to play pivotal roles in molecular diagnostics, continuous longitudinal monitoring, dynamic tissue assessment, and informed clinical decision-making. The review consolidates advancements from 2018 to July 2026, offering a unified translational framework designed to enhance system reliability, long-term performance, and overall clinical utility.

Technical & Clinical Details

The extensive analysis covers critical areas such as biorecognition elements, advanced biointerface engineering, efficient signal transduction mechanisms, the development of wearable and microneedle-based architectures, and the emergence of CRISPR-based diagnostics. Crucially, the integration of these components into microphysiological systems is highlighted. The success of continuous glucose monitoring (CGM) is presented as a benchmark, with its enabling factors dissected. Concurrently, the review addresses the persistent challenges hindering widespread adoption of other biosensor platforms, including biofouling in biological environments, matrix effects from complex biological samples, the intricacies of precise and stable calibration, and the inherent difficulties in scalable manufacturing. Overcoming these obstacles is identified as essential for broader clinical implementation.

Background & Context

The trajectory of biosensor technology is deeply intertwined with the increasing demand for personalized and preventive medicine. Real-time and continuous monitoring of physiological parameters has become paramount in managing chronic diseases and promoting wellness. However, translating cutting-edge research from laboratory settings to practical clinical applications involves navigating numerous hurdles beyond mere technical prowess. These include ensuring long-term operational reliability, guaranteeing patient safety, and achieving cost-effectiveness at scale. This review systematically addresses these gaps, offering a detailed perspective on the current state and future needs of the field.

Strategic Significance & Outlook

The unified translational framework proposed in this review is expected to catalyze a more practical and clinically focused approach in the next generation of biosensor development. Future research priorities will likely center on creating novel anti-fouling materials, leveraging AI for enhanced data analysis and calibration accuracy, and standardizing manufacturing processes to ensure reproducibility and affordability. By addressing these strategic points, biosensors are projected to become increasingly central to a comprehensive digital health ecosystem, spanning diagnosis, therapy management, and preventive health strategies.

Source: https://www.mdpi.com/2079-6374/16/9/477

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.